Gene set category | Drug | Direction of regulation | Gene set name | Sizea | NESb | NOM p valuec | FDR q valued |
---|---|---|---|---|---|---|---|
Reactome gene sets | IFX | REM > NON-REM | – | – | – | – | – |
NON-REM > REM | Inflammasomes (M1072) | 16 | 1.95 | <0.00001 | 0.07489 | ||
TCZ | REM > NON-REM | – | – | – | – | – | |
NON-REM > REM | – | – | – | – | – | ||
ABT | REM> NON-REM | – | – | – | – | – | |
NON-REM > REM | Elongation arrest and recovery (M810) | 27 | 1.91 | 0.00180 | 0.08880 | ||
Regulation of apoptosis (M733) | 54 | 1.96 | 0.00192 | 0.09083 | |||
Formation of RNA pol II elongation complex (M805) | 38 | 1.85 | <0.00001 | 0.09138 | |||
Blood cell gene sets | IFX | REM > NON-REM | – | – | – | – | – |
NON-REM > REM | – | – | – | – | – | ||
TCZ | REM > NON-REM | Specific CD19 (Watkins et al., 2009 [15]) | 140 | −1.70 | 0.00602 | 0.02646 | |
B-cell-induced (Allantaz et al., 2012 [16]) | 57 | −1.56 | 0.01603 | 0.08882 | |||
NON-REM > REM | – | – | – | – | – | ||
ABT | REM > NON-REM | – | – | – | – | – | |
NON-REM > REM | Specific CD56 (Watkins et al., 2009 [15]) | 51 | 1.60 | 0.02390 | 0.02615 | ||
NK-cell-induced (Allantaz et al., 2012 [16]) | 78 | 1.63 | 0.00403 | 0.02861 |